57 related articles for article (PubMed ID: 25951023)
1. ASCCP Practice Guidelines: The Follow-Up System for Abnormal Cervical Cytological Findings.
Cox JT
J Low Genit Tract Dis; 1997 Jul; 1(3):167-70. PubMed ID: 25951023
[No Abstract] [Full Text] [Related]
2. Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000-2005.
Benard VB; Howe W; Saraiya M; Helsel W; Lawson HW
J Low Genit Tract Dis; 2008 Oct; 12(4):300-6. PubMed ID: 18820545
[TBL] [Abstract][Full Text] [Related]
3. Follow-up for cervical abnormalities in a managed care plan, 1999-2004.
Benard VB; Berkman ND; Kuo T; Martin CK; Richardson LC
Prev Med; 2010; 50(1-2):81-5. PubMed ID: 19932710
[TBL] [Abstract][Full Text] [Related]
4. ASCCP Practice Guidelines Management Guidelines for the Follow-up of Atypical Squamous Cells of Undetermined Significance (ASCUS).
Cox TJ; Wilkinson EJ; Lonky N; Waxman A; Tosh R; Tedeschi C
J Low Genit Tract Dis; 2000 Apr; 4(2):99-105. PubMed ID: 25950896
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for screening and treatment of cervical disease in the adolescent.
Guido R
J Pediatr Adolesc Gynecol; 2004 Oct; 17(5):303-11. PubMed ID: 15581775
[TBL] [Abstract][Full Text] [Related]
6. The 2006 consensus guidelines for the management of women with abnormal cervical screening tests: challenges remain.
Colgan TJ
Cancer Cytopathol; 2010 Oct; 118(5):233-7. PubMed ID: 20629030
[TBL] [Abstract][Full Text] [Related]
7. ASCCP Practice Guidelines Management Guidelines for the Follow-up of Cytology Read as Low Grade Squamous Intraepithelial Lesion.
Cox TJ; Massad SL; Lonky N; Tosh R; Waxman A; Wilkinson EJ
J Low Genit Tract Dis; 2000 Apr; 4(2):83-92. PubMed ID: 25950894
[No Abstract] [Full Text] [Related]
8. ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators.
Davey DD; Austin RM; Birdsong G; Buck HW; Cox JT; Darragh TM; Elgert PA; Hanson V; Henry MR; Waldman J;
Am J Clin Pathol; 2002 Nov; 118(5):714-8. PubMed ID: 12428791
[TBL] [Abstract][Full Text] [Related]
9. ASCCP Practice Guidelines Management Guidelines for the Follow-up of Cytology Interpreted as Benign Cellular Changes on Papanicolaou Smear of the Cervix or Vagina.
Wilkinson EJ
J Low Genit Tract Dis; 2000 Apr; 4(2):93-8. PubMed ID: 25950895
[No Abstract] [Full Text] [Related]
10. The influence of ASCCP guideline changes on family medicine residency colposcopy training.
Keehbauch J; Green L; Lugo N; Pepe J
Fam Med; 2012 Oct; 44(9):650-3. PubMed ID: 23027158
[TBL] [Abstract][Full Text] [Related]
11. [False negative reactions of cervical cytological examinations and defective follow-up after demonstration of abnormal cervical cytological findings].
Olesen F
Ugeskr Laeger; 1987 Dec; 149(52):3571-4. PubMed ID: 3433574
[No Abstract] [Full Text] [Related]
12. [Follow up after an abnormal pap smear: time interval acceptable, nature of follow up leaves room for improvement].
Geertsen M; Bais AG; Beerman H; Helmerhorst TJ
Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2430-4. PubMed ID: 14694554
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the follow-up of women aged 50-74 years after cervical cytological Ascus abnormalities in cancer screening: adherence to clinical practice guidelines in Isere, France; 1991-2000].
Billette-de-Villemeur A; Poncet F; Garnier A; Marron J; Le Marc'hadour F; Morens A; Rouault-Plantaz V; Ney M; Exbrayat C
Gynecol Obstet Fertil; 2009 Oct; 37(10):787-95. PubMed ID: 19782628
[TBL] [Abstract][Full Text] [Related]
14. [New guidelines for prevention of cervix cancer. ARG report on investigation and treatment of abnormal cytological smears].
Strander B; Elfgren K; Andrae B
Lakartidningen; 2011 Mar 9-15; 108(10):533-5. PubMed ID: 21744553
[No Abstract] [Full Text] [Related]
15. [Follow-up not according to guidelines after an abnormal cervix smear].
Kreuger FA; Beerman H; Nijs HG; Wijnen JA
Ned Tijdschr Geneeskd; 1996 Apr; 140(15):833-6. PubMed ID: 8668277
[TBL] [Abstract][Full Text] [Related]
16. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
17. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.
Fontaine PL; Saslow D; King VJ
Am Fam Physician; 2012 Sep; 86(6):501, 506-7. PubMed ID: 23062041
[No Abstract] [Full Text] [Related]
18. Impact of the 2002 American society for Colposcopy and Cervical Pathology guidelines on cervical cancer diagnosis in a geographically diverse population of commercially insured women, 1999-2004.
Martin CK; Richardson LC; Berkman ND; Kuo TM; Yuen AN; Benard VB
J Low Genit Tract Dis; 2011 Jan; 15(1):25-32. PubMed ID: 21192173
[TBL] [Abstract][Full Text] [Related]
19. Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Perkins RB; Guido RS; Castle PE; Chelmow D; Einstein MH; Garcia F; Huh WK; Kim JJ; Moscicki AB; Nayar R; Saraiya M; Sawaya GF; Wentzensen N; Schiffman M;
J Low Genit Tract Dis; 2021 Oct; 25(4):330-331. PubMed ID: 34542089
[No Abstract] [Full Text] [Related]
20. [Update on current care guidelines. Diagnosis, treatment and follow-up of cytological changes in the cervix, vagina and vulva].
Pekka N; Anttila A; Bützow R; Heikkilä E; Hiltunen-Back E; Mäenpää J; Puistola U; Rantanen V; Rintala M; Räisänen I; Santalahti A; Talvensaari-Mattila A; Vartiainen J; Vuento M; Yliskoski M;
Duodecim; 2010; 126(16):1965-6. PubMed ID: 20957796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
